The Institute of Esophageal and Reflux Surgery is studying a new, non-surgical, one-time endoscopic injection to treat acid reflux (GERD). The NECTAR clinical study is offered to patients who have taken anti-reflux medications for at least 6 months and currently experience GERD symptoms. Learn more at www.NECTARStudy.com. The NECTAR clinical trial is conducted at multiple centers across the US to study a new, non-surgical, non-medication option for chronic heartburn or acid reflux (GERD). IERSurgery is participating in the NECTAR study and invites you to learn more here.

Contact IERSuregery online or by phone at (303) 788-1636 to be considered for the NECTAR clinical study.

Are you suffering from heartburn

Are you suffering from heartburn?

Consider a clinical trial for adults living with heartburn (GERD)

What is GERD

What is GERD?

Gastroesophageal reflux disease (GERD) is a chronic digestive disease. GERD occurs when stomach acid (or occasionally stomach content) flows back into your esophagus. The acid reflux irritates the lining of your esophagus and causes GERD.1

What are GERD symptoms?

  1. A burning sensation in the chest (heartburn), sometimes spreading to the throat, along with a sour taste in the mouth
  2. Chest pain
  3. Difficulty swallowing
  4. Dry cough
  5. Hoarseness or sore throat
  6. Regurgitation of food or sour liquid (acid reflux)
  7. Sensation of a lump in the throat

Nearly 65 million adult Americans (1 in 4) have weekly GERD symptoms.2

  1. Mayo Clinic, Disease & Condition GERD, http://www.mayoclinic.org/diseases-conditions/gerd/basics/symptoms/con-20025201. Accessed September 13, 2017.
  2. National Institute of Diabetes and Digestive and Kidney Disease, Definition & Facts for GER & GERD, https://www.niddk.nih.gov/health-information/digestive-diseases/acid-reflux-ger-gerd-adults/definition-facts. Accessed September 22, 2017.

What is the NECTAR clinical trial

What is the NECTAR clinical trial?

The Novel Endoluminal Clinical TreAtment of Reflux (NECTAR) trial will evaluate the performance of Aluvra™ for the treatment of GERD.

Aluvra is an injectable material composed of tiny carbon beads in a gel. Aluvra is a nonreactive material that cannot be absorbed.

Aluvra is injected in an area of the lower esophagus in a one-time procedure during GI endoscopy with no hospital stay.

This clinical trial lasts for 12 months following the injection.

Do I qualify for the NECTAR clinical trial?

You may qualify if you meet the following requirements:

  1. Have taken GERD medication for at least 6 months
  2. GERD symptoms are not completely resolved by medication
  3. Not pregnant
  4. Male or female
  5. At least 22 years old
  6. Diagnosed with GERD
  7. No prior gastric or GERD surgery

Contact clinical trial site near you

Dr. Reginald Bell

The Institute of Esophageal and Reflux Surgery

499 East Hampden Ave, Englewood, CO 80113

Dr. Reginald Bell, Principal Investigator

Rachel Heidrick, Study Coordinator

Tel: 303-788-1636

Email: Rachel@sofisite.com

CAUTION: Aluvra™ is not approved for sales in the U.S. Limited by US federal law to investigational use only